Executive Director, Global Value and Access, HIV in London

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

We are now hiring for the role of Executive Director, Global Value and Access, HIV. This role reports to our Global Head of Value and Access, and has responsibility for leading our value and access strategy for Gilead’s HIV portfolio.

• Lead a high-performing team to develop and execute robust global value and access strategies across the HIV therapeutic area (TA), including:

• Setting a clear direction for value strategy across the TA
• Providing guidance and input to strategic decisions including development, study design and acquisitions
• Developing new capabilities to deal with emerging threats and opportunities
• Oversee the generation of the global V&A strategy, integrated evidence plans, value story, and stakeholder engagement planning for TA-specific assets
• Partner with Global Strategy Marketing (GSM) TA Lead to ensure alignment of V&A strategy with the global brand strategy.
• Partner with key markets to develop new funding streams for HIV prevention
• Understand potential and value propositions for pipeline concepts
• Ensure collaboration with cross-functional partners (Clin Dev, Medical Affairs, Government Affairs, and other global and local commercial counterparts) to develop a comprehensive TA strategy and business priorities.
• Represent TA from a V&A perspective, providing a comprehensive view of the global priority Affiliates (G9) to the team and cross-functional partners, including Clin Dev, and ensuring the payer perspective is reflected in the overall product commercial and development strategy.
• Guide the development and implementation of global value and access strategies for TA-specific assets throughout the product lifecycle, from pre-clinical to post-launch, drawing on health economics, pricing models, payer landscapes, and global evidence requirements to maximize product value and patient access.
• Deliver strategic leadership as an active member of GV&A's leadership team (LT) and shaping the team’s strategy, priorities, and activities.

• Bachelor's Degree OR Masters' Degree OR Ph.D. and Relevant Experience

• Relevant commercial experience in the biotech or pharmaceutical industry, including some market access-related activities
• Experience working at a global/regional level or in more than one country
• Advanced degree in life sciences, health policy or medical degree
• Demonstrated ability to shape policy environment to support development of new funding streams
• Understanding of payer environment, including coverage and reimbursement, pricing and contracting, formulary management, HTA, and payment policy.
• Expertise in strategic pricing, contracting and negotiation, including innovative approaches and experience developing pricing strategies and business cases.
• Advanced understanding of the pharmaceutical product lifecycle, including experience with market access launch planning, execution, and drivers of value.
• Significant experience developing global V&A strategies, including developing global value messages, integrated evidence planning and creating tools to support implementation in key markets.
• Experience with early-stage assets, including conducting commercialization assessments and providing V&A guidance into target product profiles and development plans.
• Proven track record managing a high-performing team, building a distinctive team culture in a globally dispersed team, and developing people through coaching and mentoring.
• Demonstrated ability to lead and influence cross-functionally while serving as a highly-skilled facilitator, negotiator, and counselor.
• Experience in HIV treatment or prevention is helpful but not required
• Broader commercial experience beyond value and access is a plus